ARMP
ARMP
Positions held
Your positionsARMP isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | — | Enterprise value | — | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | — | Beta | — | Dividend yield | — |
| Revenue growth | — | Earnings growth | — | Gross margin | — | Operating margin | — |
| Profit margin | — | ROE | — | ROA | — | Debt / equity | — |
| Current ratio | — | Free cash flow | — | Analyst recommendation | — | Mean target | — |
| 52w high | — | 52w low | — |
Quarterly
No data yet.
Yearly (6y)
No data yet.
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-14 · Armata Pharmaceuticals Shares Rise 8% After FDA Grants AP-SA02 Breakthrough Therapy Designation
2026-09-14 · Armata Pharmaceuticals' AP-SA02 Gets FDA Breakthrough Therapy Designation
2026-09-14 · Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
2026-09-10 · Armata Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-08-12 · Armata Pharmaceuticals Announces Financial Results for the Second Quarter 2026 and Provides a Corporate Update
2026-07-21 · Armata Pharmaceuticals (ARMP) Stock Jumps 12.2%: Will It Continue to Soar?
2026-07-20 · Armata Pharmaceuticals Names David House as CFO; Advances Staphylococcus Aureus Treatment Candidate
Price (daily)
Full chart · RSI · MACD · patterns